Isolated central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm: a rare case of relapse during systemic remission with diagnostic and therapeutic implications. [PDF]
Zhao H, Huang W, Lin S, Chen Y.
europepmc +1 more source
Finite-Duration Venetoclax/Azacitidine Followed by Umbilical Cord Blood Infusion Improves Outcomes in Frail Elderly Patients With Untreated Acute Myeloid Leukemia-A Pilot Study. [PDF]
Ye L +11 more
europepmc +1 more source
Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma. [PDF]
Li Q +6 more
europepmc +1 more source
Comparative efficacy and safety of systemic therapies in transplant-eligible and ineligible relapsed/refractory large B-cell lymphoma: a Bayesian network meta-analysis. [PDF]
Huang L +7 more
europepmc +1 more source
Implementation of Natural Products and Derivatives in Acute Myeloid Leukemia Management: Current Treatments, Clinical Trials and Future Directions. [PDF]
Merhi F, Dauzonne D, Bauvois B.
europepmc +1 more source
Recurrent cytarabine-induced sinus bradycardia in a patient with acute myeloid leukemia: a case report and review of the literature. [PDF]
Tesfaye T +5 more
europepmc +1 more source
FLT3 Testing and Guideline Concordance in Acute Myeloid Leukemia Across a Community Health System. [PDF]
Yawn C +3 more
europepmc +1 more source
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients. [PDF]
Fathima S +29 more
europepmc +1 more source
Single-center analysis of relapse risk factors and prognosis in 256 cases of ETV6::RUNX1-positive pediatric acute lymphoblastic leukemia. [PDF]
Hu B, Hu F, He H, Kong L.
europepmc +1 more source
Epidemiology, Risk Factors, and Outcomes of Neutropenic Enterocolitis in Onco-Hematological Patients According to Chemotherapy Regimen. [PDF]
Brunel AS +12 more
europepmc +1 more source

